What's in Universidad de Cartagena's pipeline?

Universidad de Cartagena has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Universidad de Cartagena's portfolio?

Top competitors by shared drug class: Erasme University Hospital, Henry M. Jackson Foundation for the Advancement of Military Medicine, Kasr El Aini Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidad-de-cartagena.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universidad de Cartagena — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidad de Cartagena pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Midazolam+Ketamine Combination	Midazolam+Ketamine Combination	marketed	Sedative-hypnotic and dissociative anesthetic combination	GABA-A receptor (midazolam); NMDA receptor (ketamine)	Anesthesia and Sedation
Ketamina-Propofol Combination	Ketamina-Propofol Combination	marketed	Anesthetic combination	NMDA receptor (ketamine); GABA-A receptor (propofol)	Anesthesiology
Midazolam+Fentanyl Combination	Midazolam+Fentanyl Combination	marketed	Benzodiazepine + Opioid combination	GABA-A receptor (midazolam); Mu-opioid receptor (fentanyl)	Anesthesia, Sedation, Pain Management

Therapeutic area mix

Anesthesia and Sedation · 1
Anesthesia, Sedation, Pain Management · 1
Anesthesiology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Erasme University Hospital · 1 shared drug class
Henry M. Jackson Foundation for the Advancement of Military Medicine · 1 shared drug class
Kasr El Aini Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidad de Cartagena:

Cite this brief

Drug Landscape (2026). Universidad de Cartagena — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-de-cartagena. Accessed 2026-05-17.